Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 33 of 167 for:    trisomy21 NOT prenatal

Correlations Phenotype / Genotype in Down Syndrome (INTREPID)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01034280
Recruitment Status : Completed
First Posted : December 17, 2009
Last Update Posted : March 22, 2012
Sponsor:
Collaborator:
Fondation Jérôme Lejeune
Information provided by (Responsible Party):
Institut Jerome Lejeune

Tracking Information
First Submitted Date December 16, 2009
First Posted Date December 17, 2009
Last Update Posted Date March 22, 2012
Study Start Date March 2004
Primary Completion Date Not Provided
Current Primary Outcome Measures Not Provided
Original Primary Outcome Measures Not Provided
Change History Complete list of historical versions of study NCT01034280 on ClinicalTrials.gov Archive Site
Current Secondary Outcome Measures Not Provided
Original Secondary Outcome Measures Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Correlations Phenotype / Genotype in Down Syndrome
Official Title Epidemiological Study of Trisomy 21 With Research of Correlations Between Phenotype (Physical, Psychometrical) and Genotype (Genome, Transcriptome, Proteome)
Brief Summary The purpose of this study is to correlate phenotype and genotype of Down syndrome patients in order to identify the biochemical reactions involved in their mental retardation and their other phenotypic characteristics.
Detailed Description Not Provided
Study Type Observational
Study Design Observational Model: Case-Only
Time Perspective: Cross-Sectional
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Probability Sample
Study Population Down syndrome patients
Condition Down Syndrome
Intervention Not Provided
Study Groups/Cohorts Not Provided
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Completed
Actual Enrollment
 (submitted: March 21, 2012)
524
Original Estimated Enrollment
 (submitted: December 16, 2009)
800
Actual Study Completion Date May 2011
Primary Completion Date Not Provided
Eligibility Criteria

Inclusion Criteria:

  • Down syndrome patients
  • age: 8years and older
  • assessment by the psychometric tests
  • possible blood tests

Exclusion Criteria:

  • no exclusion criteria
Sex/Gender
Sexes Eligible for Study: All
Ages 8 Years and older   (Child, Adult, Older Adult)
Accepts Healthy Volunteers No
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries France
Removed Location Countries  
 
Administrative Information
NCT Number NCT01034280
Other Study ID Numbers IJL-PG-EP03
Intrepid
Has Data Monitoring Committee Not Provided
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement Not Provided
Responsible Party Institut Jerome Lejeune
Study Sponsor Institut Jerome Lejeune
Collaborators Fondation Jérôme Lejeune
Investigators
Study Director: Yann Grattau, M.D. Institut Jerome Lejeune
PRS Account Institut Jerome Lejeune
Verification Date December 2009